Crossmark Global Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$242K Buy
1,003
+37
+4% +$8.93K ﹤0.01% 1192
2025
Q1
$235K Buy
966
+123
+15% +$30K ﹤0.01% 1194
2024
Q4
$277K Sell
843
-384
-31% -$126K 0.01% 1072
2024
Q3
$411K Sell
1,227
-595
-33% -$199K 0.01% 949
2024
Q2
$498K Buy
1,822
+97
+6% +$26.5K 0.01% 837
2024
Q1
$597K Sell
1,725
-152
-8% -$52.6K 0.01% 786
2023
Q4
$606K Sell
1,877
-30
-2% -$9.69K 0.01% 766
2023
Q3
$696K Buy
1,907
+21
+1% +$7.66K 0.02% 683
2023
Q2
$786K Sell
1,886
-285
-13% -$119K 0.02% 665
2023
Q1
$1.04M Sell
2,171
-258
-11% -$124K 0.02% 574
2022
Q4
$1.02M Buy
2,429
+368
+18% +$155K 0.03% 562
2022
Q3
$859K Sell
2,061
-112
-5% -$46.7K 0.02% 585
2022
Q2
$1.08M Buy
2,173
+270
+14% +$134K 0.03% 545
2022
Q1
$1.07M Sell
1,903
-150
-7% -$84.5K 0.02% 597
2021
Q4
$1.55M Sell
2,053
-2,650
-56% -$2M 0.03% 501
2021
Q3
$3.51M Sell
4,703
-360
-7% -$269K 0.08% 252
2021
Q2
$3.26M Sell
5,063
-140
-3% -$90.2K 0.08% 265
2021
Q1
$2.97M Sell
5,203
-800
-13% -$457K 0.07% 275
2020
Q4
$3.5M Buy
6,003
+3,560
+146% +$2.08M 0.09% 250
2020
Q3
$1.26M Buy
2,443
+400
+20% +$206K 0.04% 467
2020
Q2
$922K Buy
2,043
+218
+12% +$98.4K 0.03% 557
2020
Q1
$640K Sell
1,825
-70
-4% -$24.5K 0.02% 585
2019
Q4
$701K Sell
1,895
-400
-17% -$148K 0.02% 669
2019
Q3
$764K Sell
2,295
-104
-4% -$34.6K 0.02% 615
2019
Q2
$750K Sell
2,399
-142
-6% -$44.4K 0.02% 633
2019
Q1
$777K Buy
2,541
+110
+5% +$33.6K 0.02% 626
2018
Q4
$565K Sell
2,431
-402
-14% -$93.4K 0.02% 719
2018
Q3
$887K Sell
2,833
-153
-5% -$47.9K 0.02% 655
2018
Q2
$862K Sell
2,986
-194
-6% -$56K 0.02% 664
2018
Q1
$795K Sell
3,180
-412
-11% -$103K 0.02% 688
2017
Q4
$857K Sell
3,592
-445
-11% -$106K 0.02% 697
2017
Q3
$897K Buy
+4,037
New +$897K 0.02% 652
2016
Q3
$897K Buy
+4,037
New +$897K 0.02% 652